Sling Therapeutics
Business Services · Michigan, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
455 E Eisenhower Pkwy Ste 300 PMB 109, A...Website
www.slingtx.comRevenue
<$5 MillionIndustry
About Sling Therapeutics
Sling Therapeutics is a clinical-stage biopharmaceutical company focused on developing oral small-molecule therapies for thyroid eye disease (TED). Its lead drug candidate, linsitinib, is a small-molecule IGF-1R inhibitor in Phase 3 clinical development designed to reduce proptosis and inflammation without the treatment burden of traditional IV biologic infusionsExplore more
SIC Code 87,873NAICS Code 54,541Show moreSling Therapeutics Org Chart
Compare Similar Companies to Sling Therapeutics
Compare insights from companies similar to Sling Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sling Therapeutics Tech Stack
A closer look at the technologies used by Sling Therapeutics
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Sling Therapeutics
Sign Up For FreeTo access detailed company insights
Sling Therapeutics is a clinical-stage biopharmaceutical company focused on developing oral small-molecule therapies for thyroid eye disease (TED). Its lead drug candidate, linsitinib, is a small-molecule IGF-1R inhibitor in Phase 3 clinical development designed to reduce proptosis and inflammation without the treatment burden of traditional IV bio... Read More
